1,080 material Form 8-K filings that 839 companies we cover made with the SEC in May 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Toll Brothers reported fiscal second-quarter 2025 results for the period ended April 30, 2025, with net income of $352.4 million, or $3.50 per diluted share, down from $481.6 million, or $4.55, a year earlier. The prior-year figure included a $124.1 million gain from a land sale; excluding that gain, the company's prior-year diluted EPS was $3.38. The company reaffirmed its full-year fiscal 2025 guidance, but net signed contract value fell 11% to $2.60 billion.
Home sales revenues were $2.71 billion, up 2% from the prior-year quarter; 2,899 homes were delivered, up 10%.
Net signed contract value was $2.60 billion, down 11%; contracted homes fell 13% to 2,650.
Home sales gross margin was 26.0%, up from 25.8%; adjusted home sales gross margin fell to 27.5% from 28.2%.
Full-year fiscal 2025 guidance was reaffirmed; the company repurchased about 1.6 million shares for $177.4 million in the quarter.
Merit Medical completed its merger with Biolife on May 20, 2025, paying about $120 million in cash on hand, and updated its 2025 guidance to include the business. Net sales guidance was raised to $1.480 billion to $1.501 billion from $1.470 billion to $1.490 billion, while the non-GAAP earnings per share range moved to $3.28 to $3.41 from $3.29 to $3.42. Management said the deal will be slightly dilutive to 2025 non-GAAP profitability.
Purchase price of about $120 million, subject to standard adjustments, paid with available cash; merger effective May 20, 2025
Biolife projected to contribute $10 million to $11 million of revenue from May 20 to December 31, 2025, after about $15 million in revenue for the twelve months ended December 31, 2024
2025 net sales guidance raised to $1.480 billion to $1.501 billion; non-GAAP EPS guidance $3.28 to $3.41 versus prior $3.29 to $3.42
About $7.2 million of non-cash and non-recurring transaction expenses excluded from non-GAAP projections; deal projected to be dilutive to 2025 GAAP net income and EPS
Viasat reported fourth quarter and fiscal 2025 results in a shareholder letter filed with the SEC. Quarterly revenue was flat year over year, and the net loss widened to $246 million, including a $169 million ViaSat-3 EMEA ground network write-down, while the full-year net loss improved to $575 million on record revenue of $4.5 billion. The company expects low single-digit revenue growth and flattish Adjusted EBITDA in fiscal 2026.
Q4 FY2025 revenue was $1.1 billion, flat year over year; Q4 net loss was $246 million versus $90 million in Q4 FY2024.
The Q4 loss included a $169 million charge tied to the ViaSat-3 EMEA ground network, of which $104 million was non-cash asset write-downs.
FY2025 revenue was a record $4.5 billion, and the net loss improved to $575 million from the prior year.
For FY2026, the company expects low single-digit revenue growth and flattish Adjusted EBITDA, with capital expenditures of approximately $1.3 billion.
Eagle Materials reported fourth-quarter fiscal 2025 results for the quarter ended March 31, 2025, with revenue of $470.2 million, down 1%, and net earnings of $66.5 million, down 14%. For the full fiscal year, revenue reached a record $2.3 billion, but net earnings fell 3% to $463.4 million while record diluted EPS of $13.77 rose 1%, helped by share repurchases of 1.2 million shares for $298 million.
Q4 revenue of $470.2 million, down 1%; diluted EPS of $2.00, down 11%; adjusted EPS of $2.08, down 7%
Management cited adverse weather in the first two months of calendar 2025 and higher production costs, including a pulled-forward maintenance outage at Texas Lehigh cement facility
Fiscal 2025 record revenue of $2.3 billion; net earnings of $463.4 million, down 3%; record diluted EPS of $13.77, up 1%
Eagle announced a $330 million investment to modernize and expand its Duke, OK Gypsum Wallboard plant, with startup scheduled for the second half of calendar 2027
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.